Strongyloidiasis - Progress in diagnosis and treatment

Citation
O. Zaha et al., Strongyloidiasis - Progress in diagnosis and treatment, INTERN MED, 39(9), 2000, pp. 695-700
Citations number
12
Categorie Soggetti
General & Internal Medicine
Journal title
INTERNAL MEDICINE
ISSN journal
09182918 → ACNP
Volume
39
Issue
9
Year of publication
2000
Pages
695 - 700
Database
ISI
SICI code
0918-2918(200009)39:9<695:S-PIDA>2.0.ZU;2-5
Abstract
Strongyloidiasis is an intestinal parasitic disease caused by Strongyloides stercoralis, Basically, detecting larvae of S. stercoralis in feces makes definitive diagnosis. The ordinary agar plate culture method developed at o ur department is much simpler to handle and much more sensitive than the co nventional filter paper culture method. It is considered to be the most use ful method in the diagnosis of strongyloidiasis and in evaluation of the er adicating effect. Among chemotherapeutic agents, thiabendazole representing the benzimidazole compounds is most effective. However, it has a problem i n safety, since its adverse effects and liver dysfunction occur with a high incidence, and it can be severe. Regarding the effects of mebendazole, alb endazole and ivermectin, a study was conducted which included many patients . A high incidence of liver dysfunction was observed with mebendazole, and eradicating effect was not sufficient with albendazole, Ivermectin is diffe rent from benzimidazole compounds in a pharmacokinetic profile, However, iv ermectin showed a strong anthelmintic effect with the least toxicity. We th erefore consider ivermectin is the most useful drug for the treatment of st rongyloidiasis.